The Brazilian Health Regulatory Agency has approved importation and marketing of a Columbian cannabis-based medical product. The product contains 50mg/ml of cannabidiol and up to 0.2% tetrahydrocannabinol. The product will be available by prescription for patients suffering from epilepsy.

Source: https://www.riotimesonline.com/brazil-news/rio-politics/brazil-authorizes-use-of-cannabis-based-medicine-imported-from-colombia/